r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

FL

Foresite Capital Management V, LLC

Insider · 10% owner · LTGO

Foresite Capital Management V, LLC files insider transactions with the SEC as a 10% owner of Latigo Biotherapeutics. We hold 1 disclosed purchase or sale filed since 28 December 2021, 1 of them in the last 90 days.

  • Files for 2 companiesLTGO, PRDS
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure10 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 10 August 2026 — 10 August 202610% owner · Latigo Biotherapeutics 15 Form 4 lines · source: SEC Form 4
  • Filed 23 December 2021 — 23 December 202110% owner · Pardes Biosciences 5 Form 4 lines · source: SEC Form 4

Every transaction

20 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
20 of 20 shown
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeutics3,117,664 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeuticsderivative445,320 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeuticsderivative1,125,823 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeuticsderivative742,201 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeuticsderivative3,117,664 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeuticsderivative296,880 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeuticsderivative195,776 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeutics445,320 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeutics1,125,823 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeutics742,201 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dbought on the open marketLatigo Biotherapeutics140,000 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeutics195,776 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeutics3,117,664 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeutics296,880 sharesup +22.8%up +22.8%
10 Aug 202610 Aug 2026SEC Form 40 dconvertednot a tradeLatigo Biotherapeuticsderivative3,117,664 sharesup +22.8%up +22.8%
23 Dec 202128 Dec 2021SEC Form 45 dconvertednot a tradePRDSPardes Biosciencesderivative4,873,750 shares——
23 Dec 202128 Dec 2021SEC Form 45 dwas grantednot a tradePRDSPardes Biosciencesderivative75,000 shares——
23 Dec 202128 Dec 2021SEC Form 45 dwas grantednot a tradePRDSPardes Biosciences1,000,000 shares——
23 Dec 202128 Dec 2021SEC Form 45 dconvertednot a tradePRDSPardes Biosciences4,873,750 shares——
23 Dec 202128 Dec 2021SEC Form 45 dwas grantednot a tradePRDSPardes Biosciences7,759,072 shares——

Both percentages are the stock’s move, not Foresite Capital Management V, LLC’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 9 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 15 of the 20 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.